Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients.

Authors:
Camblor DG; Miranda D; Albaiceta GM; Amado-Rodríguez L; Cuesta-Llavona E and 5 more

Journal:
Hum Immunol

Publication Year: 2022

DOI:
10.1016/j.humimm.2022.06.002

PMCID:
PMC9212649

PMID:
35777990

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Hum Immunol

Abbreviation: Hum Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Combining nano-curcumin with catechin improves COVID-19-infected patient's inflammatory conditions.
Ahmad Merza Mohammad T. (2023) - Transparency Score: 3/6
Impact of HLA polymorphisms on the susceptibility to SARS-CoV-2 infection and related mortality in …
Akcay OF; Yeter HH; Unsal Y and 3 more (2023) - Transparency Score: 3/6
Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients.
Rohn H; Schramm S; Pansikaki K and 12 more (2023) - Transparency Score: 4/6
Distribution of HLA-A, -B, -C, -DRB1, -DQB1, -DPB1 allele frequencies in patients with COVID-19 bil…
Suslova TA; Vavilov MN; Belyaeva SV and 4 more (2022) - Transparency Score: 4/6
Donor-directed immunologic safety of COVID-19 vaccination in renal transplant recipients.
Kueht M; Kirk K; Scott Lea A and 5 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"appendix a supplementary data the following are the supplementary data to this article: supplementary data 1 acknowledgements this work was supported by a grant from the and the grants isciii-pi21/00971 (e c) and ricor2040- rd21/0005/0011 (e c)."

Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"AcknowledgementsThis work was supported by a grant from the Spanish Plan Nacional de I+D+I Ministerio de Economía y Competitividad and the European FEDER, grants ISCIII-PI21/00971 (E.C.) and RICOR2040- RD21/0005/0011 (E.C.)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025